Startups
AB-BIOTICS is a leading probiotics player inspired by developing probiotic solutions at the forefront of an expanding field. Whether you are interested in unique, patented strains with characterized mechanisms of action, premium probiotic solutions targeting specific therapeutic areas, or finished products with easily-communicated benefits, our agile approach allows us to adapt to your needs. With science at the heart of everything we do, our strains, blends and market-ready products are supported by robust scientific documentation. Our global footprint gives us a unique view of the ever-changing probiotic landscape enabling us to offer regulatory support in not only supplements, and functional foods but also OTC and medical applications to meet the needs of consumers worldwide.
Overview
Location
Spain, Catalonia, Sant Cugat del Vallès
Employees
51-200
Total raised
$59K
Founded date
2004
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 13, 2018 | AB Biotics cierra su nuevo consejo con la incorporación de J.M.Echarri y J.R.Ramos | 13/08/2018 Nota de prensa AB BIOTICS CIERRA SU NUEVO CONSEJO DE ADMINISTRACIÓN CON LA INCORPORACIÓN DE JOSEP MARÍA ECHARRI KY JOAN RAMÓN RAMOS. La Junta General de Accionistas de AB Biotics ha aprobado el nombramiento de los dos consejer... |
| Apr 3, 2018 | La japonesa Kaneka adquiere un 27% de AB-Biotics por €10,2M, desinvierten el ICF y familias propietarias | 03/04/2018 LA JAPONESA KANEKA ADQUIERE UN 27% DE AB-BIOTICS POR €10,2 MILLONES, DESINVIERTEN EL ICF Y FAMILIAS PROPIETARIAS. La multinacional químico-farmacéutica japonesa Kaneka, ha adquirido una participación del 27% en la biotecnológic... |
| Mar 20, 2015 | AB-Biotics, participada por Capital MAB FCR, comercializará el primer dentífrico probiótico | 20/03/2015 AB-BIOTICS, PARTICIPADA POR CAPITAL MAB FCR, COMERCIALIZARÁ EL PRIMER DENTRÍFICO PROBIÓTICO. La biotecnológica española AB-Biotics, participada por el fondo de capital riesgo Capital MAB FCR y cotizada en el Mercado Alternativo... |
| Apr 2, 2012 | AB Therapeutics ultima la captación de €300.000 de un fondo de capital riesgo | 02/04/2012 AB THERAPEUTICS ULTIMA LA CAPTACIÓN DE €300.000 DE UN FONDO DE CAPITAL RIESGO. La biofarmacéutica catalana AB Therapeutics ultima la captación de €300.000 de un fondo de capital riesgo (venture capital), además de €200.000 adic... |
Reviews 0
FAQ about AB-BIOTICS
When was AB-BIOTICS founded?
AB-BIOTICS was founded in 2004.
How much funding has AB-BIOTICS raised?
AB-BIOTICS has raised $59K in total across 1 funding round.
What has the press written about AB-BIOTICS?
Parsers VC has collected 5 articles mentioning AB-BIOTICS, among them “AB Biotics cierra su nuevo consejo con la incorporación de J.M.Echarri y J.R.Ramos” (Aug 13, 2018) and “La japonesa Kaneka adquiere un 27% de AB-Biotics por €10,2M, desinvierten el ICF y familias propietarias” (Apr 3, 2018).
Is AB-BIOTICS still active?
Yes, AB-BIOTICS is active; its latest activity on Parsers VC dates from Feb 25, 2019.